Moderate to severe psoriasis treatment challenges through the era of biological drugs
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Anais brasileiros de dermatologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000500668 |
Resumo: | Abstract: Biological therapy has revolutionized moderate to severe psoriasis treatment. However, despite being more effective than conventional systemic treatments, some patients do not respond or lose response to biotechnological treatments or develop drug-antibodies, interfering with its safety and efficacy. There are also clinical forms of the disease and patient profiles for which is pending further scientific evidence for more sustained therapeutic interventions. The continuous and more detailed knowledge of psoriasis pathophysiology has allowed identifying new therapeutic targets, which is expected to help overcome the challenges of individualized psoriasis treatment. |
id |
SBD-1_1429e1cfd78537fb42eec8bd3ef528bd |
---|---|
oai_identifier_str |
oai:scielo:S0365-05962017000500668 |
network_acronym_str |
SBD-1 |
network_name_str |
Anais brasileiros de dermatologia (Online) |
repository_id_str |
|
spelling |
Moderate to severe psoriasis treatment challenges through the era of biological drugsBiological factorsBiological therapyBiological treatmentClinical trials as topicPsoriasisTherapies, investigationalAbstract: Biological therapy has revolutionized moderate to severe psoriasis treatment. However, despite being more effective than conventional systemic treatments, some patients do not respond or lose response to biotechnological treatments or develop drug-antibodies, interfering with its safety and efficacy. There are also clinical forms of the disease and patient profiles for which is pending further scientific evidence for more sustained therapeutic interventions. The continuous and more detailed knowledge of psoriasis pathophysiology has allowed identifying new therapeutic targets, which is expected to help overcome the challenges of individualized psoriasis treatment.Sociedade Brasileira de Dermatologia2017-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000500668Anais Brasileiros de Dermatologia v.92 n.5 2017reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/abd1806-4841.20175603info:eu-repo/semantics/openAccessVide,JúliaMagina,Sofiaeng2017-11-14T00:00:00Zoai:scielo:S0365-05962017000500668Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2017-11-14T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false |
dc.title.none.fl_str_mv |
Moderate to severe psoriasis treatment challenges through the era of biological drugs |
title |
Moderate to severe psoriasis treatment challenges through the era of biological drugs |
spellingShingle |
Moderate to severe psoriasis treatment challenges through the era of biological drugs Vide,Júlia Biological factors Biological therapy Biological treatment Clinical trials as topic Psoriasis Therapies, investigational |
title_short |
Moderate to severe psoriasis treatment challenges through the era of biological drugs |
title_full |
Moderate to severe psoriasis treatment challenges through the era of biological drugs |
title_fullStr |
Moderate to severe psoriasis treatment challenges through the era of biological drugs |
title_full_unstemmed |
Moderate to severe psoriasis treatment challenges through the era of biological drugs |
title_sort |
Moderate to severe psoriasis treatment challenges through the era of biological drugs |
author |
Vide,Júlia |
author_facet |
Vide,Júlia Magina,Sofia |
author_role |
author |
author2 |
Magina,Sofia |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Vide,Júlia Magina,Sofia |
dc.subject.por.fl_str_mv |
Biological factors Biological therapy Biological treatment Clinical trials as topic Psoriasis Therapies, investigational |
topic |
Biological factors Biological therapy Biological treatment Clinical trials as topic Psoriasis Therapies, investigational |
description |
Abstract: Biological therapy has revolutionized moderate to severe psoriasis treatment. However, despite being more effective than conventional systemic treatments, some patients do not respond or lose response to biotechnological treatments or develop drug-antibodies, interfering with its safety and efficacy. There are also clinical forms of the disease and patient profiles for which is pending further scientific evidence for more sustained therapeutic interventions. The continuous and more detailed knowledge of psoriasis pathophysiology has allowed identifying new therapeutic targets, which is expected to help overcome the challenges of individualized psoriasis treatment. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000500668 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000500668 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/abd1806-4841.20175603 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Dermatologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Dermatologia |
dc.source.none.fl_str_mv |
Anais Brasileiros de Dermatologia v.92 n.5 2017 reponame:Anais brasileiros de dermatologia (Online) instname:Sociedade Brasileira de Dermatologia (SBD) instacron:SBD |
instname_str |
Sociedade Brasileira de Dermatologia (SBD) |
instacron_str |
SBD |
institution |
SBD |
reponame_str |
Anais brasileiros de dermatologia (Online) |
collection |
Anais brasileiros de dermatologia (Online) |
repository.name.fl_str_mv |
Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD) |
repository.mail.fl_str_mv |
abd@sbd.org.br||revista@sbd.org.br |
_version_ |
1752126422192750592 |